0001542874-16-000001.txt : 20160419 0001542874-16-000001.hdr.sgml : 20160419 20160419093703 ACCESSION NUMBER: 0001542874-16-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20160419 DATE AS OF CHANGE: 20160419 EFFECTIVENESS DATE: 20160419 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Achelios Therapeutics, Inc. CENTRAL INDEX KEY: 0001542874 IRS NUMBER: 454318273 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-261596 FILM NUMBER: 161578121 BUSINESS ADDRESS: STREET 1: 6340 QUADRANGLE DRIVE STREET 2: SUITE 120 CITY: CHAPEL HILL STATE: NC ZIP: 27517 BUSINESS PHONE: 919-913-4605 MAIL ADDRESS: STREET 1: 6340 QUADRANGLE DRIVE STREET 2: SUITE 120 CITY: CHAPEL HILL STATE: NC ZIP: 27517 FORMER COMPANY: FORMER CONFORMED NAME: Achelios Therapeutics LLC DATE OF NAME CHANGE: 20120221 FORMER COMPANY: FORMER CONFORMED NAME: Achelios Therapeutics DATE OF NAME CHANGE: 20120221 D 1 primary_doc.xml X0707 D LIVE 0001542874 Achelios Therapeutics, Inc. 6340 QUADRANGLE DRIVE SUITE 120 CHAPEL HILL NC NORTH CAROLINA 27517 919-354-6233 DELAWARE Achelios Therapeutics LLC Achelios Therapeutics Corporation true 2012 Crist J. Frangakis 6340 Quadrangle Drive Suite 120 Chapel Hill NC NORTH CAROLINA 27517 Executive Officer Director Ron Vered 1801 Woodward Drive Ottowa A6 ONTARIO, CANADA K2C 0R3 Director Jerry Rosenblatt 2130 Chemin Cambridge Mont-Royal A8 QUEBEC, CANADA H3R 2Y3 Director Other Health Care Decline to Disclose 06b false 2016-04-07 false true true true false 0 2000000 350000 1650000 false 2 0 0 0 Proceeds will be used for working capital, which will include normal compensation to executive officers. false Achelios Therapeutics, Inc. Crist J. Frangakis Crist J. Frangakis President 2016-04-18